Digestive symptoms in the menopause transition
Bloating, IBS-like patterns, new intolerances - “suddenly”?
After about age 40, many women report a new baseline in digestion: bloating, reflux, altered bowel habits, or new food sensitivities - even when diet has not changed. Hormones, microbiome, immune tone, and gut–brain signaling shift in the menopause transition. About 40% of women report new or worse gastrointestinal symptoms. The gut is not only digestion - it is a hormonally responsive organ networked with immunity and the nervous system. A careful internal medicine workup separates “functional” patterns from conditions that require specific treatment.
of women report new or worse digestive symptoms during perimenopause. [3]
The internal medicine lens
“The gut is not a side topic in midlife - it is central. When digestion stabilizes, many other therapies work better too.”
The gut expresses estrogen-related signaling along its length. Estrogen influences motility, barrier function, and microbiome composition. As estrogen falls in the menopause transition, motility can slow, permeability signals can change, and microbiome shifts may favor more inflammatory profiles.
The estrobolome - gut bacteria that metabolize estrogen - can influence circulating estrogen activity. A disrupted estrobolome may worsen vasomotor symptoms and mood symptoms in susceptible people.
The gut produces the majority of the body’s serotonin precursor environment - foundation for the gut–brain axis.
That axis links digestive symptoms with brain fog, sleep disruption, and anxiety in both directions.
Thyroid conversion intersects with gut health; with fatigue, evaluating thyroid and gut together often clarifies the picture (see thyroid).
New symptoms after midlife require thoughtful exclusion of organic disease: celiac disease, SIBO, inflammatory bowel disease, and colorectal cancer risk - without alarmism, with appropriate testing when indicated.
Many patients improve within months when microbiome supports, nutrition, sleep, stress, and (when appropriate) hormone therapy align.
Why Dr. Lorenz?
I do not label complex symptoms as “IBS” and stop. I evaluate inflammation markers, celiac serology when indicated, nutrient absorption, and symptom context - then coordinate endoscopy referral when warranted.
My two-visit pathway includes structured history and labs (such as calprotectin when indicated) and a plan that integrates hormonal context (see About).
What could be going on?
Differential diagnoses
“IBS” is a syndrome diagnosis after exclusion - after midlife, exclusion matters more, not less.
Celiac disease
Late diagnosis is common - screen with appropriate serology.
SIBO / dysbiosis
Small intestinal bacterial overgrowth can mimic IBS - targeted testing exists.
Food intolerances
Lactose, fructose, and histamine issues can newly appear or worsen.
Inflammatory bowel disease
Calprotectin and referral patterns help distinguish IBD from functional symptoms.
Colorectal cancer
Screening colonoscopy timing follows age and risk - important public health baseline.
Medication effects
PPIs, antibiotics, and NSAIDs can alter microbiome and symptoms - review matters.
Structured evaluation balances reassurance with safety.
What actually helps?
Evidence-based options
This section reflects current guideline recommendations [1] .
Microbiome-friendly nutrition [2]
Fiber diversity, polyphenols, and Mediterranean-style patterns show strong support for microbiome resilience and barrier health. [4]
Targeted probiotics
Strain selection should match the clinical picture - not generic “all-purpose” capsules.
Hormone therapy (HT)
When appropriate, HT may support motility and symptom burden alongside gut-focused care.
Sleep and stress
The gut–brain axis runs both directions - recovery supports digestion.
We review evidence practically - without overpromising.
When should you see a doctor?
Many perimenopause symptoms are benign, but the warning signs below should be evaluated promptly:
Blood in stool or melena
Unintentional weight loss or drenching night sweats
New persistent bowel habit change after age 45
What patients say about the clarification pathway
€490 for an online visit? I was skeptical. After 60 minutes in the first appointment, it was clear: I do not get that depth with a standard office visit.
M.
Patient, Cologne
Anonymized case example
Next step
Bloating and food sensitivities that appeared “out of nowhere”?
I connect hormones, inflammation, microbiome, and safety-net testing - then build a plan that fits.
The Perimenopause Clarification is a structured two-visit program with intake, targeted diagnostics, and a written care plan. Package price €490. Lab fees are billed separately by the laboratory (typically €80–280).
Medical sources
This page is not a substitute for individualized medical advice. Key clinical statements link to the sources below.
- [1] NICE Guideline NG23: Menopause - diagnosis and management (NICE, 2024, Leitlinie) Open source
- [2] The 2022 hormone therapy position statement of The North American Menopause Society (Menopause, 2022, Positionspapier) Open source
- [3] Estrogen-gut microbiome axis: Physiological and clinical implications (Maturitas, 2017, Narrative Review) Open source
- [4] Systematic Review and Meta-analysis: Changes of Gut Microbiota before and after Menopause (Disease Markers, 2022, Meta-Analyse) Open source
Last clinically reviewed 2026-04-15. Reviewed by Dr. med. Christin Lorenz (Ärztin mit internistischem Schwerpunkt).
From the journal
In-depth articles on this topic (German)